Health2Sync and Novo Nordisk Pharma Korea, Ltd. Launch Smart Cap Mallya® for FlexTouch® Insulin Pens Integration in South Korea, Enhancing insulin administration via Digital Diabetes Care

By
Media Outreach
-
0
SEOUL, SOUTH KOREA – Media OutReach Newswire – 9 July 2025 – Health2Sync, Asia’s leading digital chronic disease management platform, announced the successful integration of Smart Cap Mallya® for FlexTouch® Insulin Pens data into SugarGenie, its Korean-market diabetes management app. Mallya® enables automatic recording of insulin injection details. This data can be synced directly into a patient’s digital health record and shared with healthcare providers via SugarGenie, HealthSync’s solution in Korea.

https://www.health2sync.com/

The issuer is solely responsible for the content of this announcement.

Health2Sync

Founded in 2013, Health2Sync is a leading digital health company in Asia focused on delivering personalized and comprehensive solutions for chronic disease management. Its core offerings include a mobile patient app and a cloud-based analytics platform for healthcare providers, designed to drive measurable improvements in blood glucose outcomes.

With the most extensive clinical network in Asia, Health2Sync offers a scalable, data-driven approach to diabetes care. The platform empowers patients with tailored insights, enabling healthcare professionals and caregivers to support them remotely and fostering continuous, collaborative care throughout the entire treatment journey.

For more information, please visit .

About SugarGenie App

Health2Sync’s SugarGenie app collects biometric information measured by medical devices and transmits it to a platform via encrypted protocols, allowing patient data to be shared with family, caregivers, and healthcare institutions.5 It integrates data such as blood glucose level, blood pressure, weight, and user-inputted dietary and exercise information. It transforms it into visual reports to provide personalized feedback, enable effective communication between patients and healthcare professionals, and monitor real-time health status. As of June 2025, Health2Sync has over 1.5 million users worldwide.